Cas:769944-79-8 4-(4-Bromophenyl)piperidine hydrochloride manufacturer & supplier

We serve Chemical Name:4-(4-Bromophenyl)piperidine hydrochloride CAS:769944-79-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(4-Bromophenyl)piperidine hydrochloride

Chemical Name:4-(4-Bromophenyl)piperidine hydrochloride
CAS.NO:769944-79-8
Synonyms:Piperidine, 4-(4-bromophenyl)-, hydrochloride (1:1);4-(4-Bromophenyl)piperidine hydrochloride (1:1);4-(4-bromophenyl)piperidine,hydrochloride
Molecular Formula:C11H15BrClN
Molecular Weight:276.600
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:340.5ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:12.03000
Exact Mass:275.007629
LogP:4.04690

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Piperidine, 4-(4-bromophenyl)-, hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(4-bromophenyl)piperidine,hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Piperidine, 4-(4-bromophenyl)-, hydrochloride (1:1) Use and application,Piperidine, 4-(4-bromophenyl)-, hydrochloride (1:1) technical grade,usp/ep/jp grade.


Related News: “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 3-Chloro-4-methoxybenzenesulfonyl chloride manufacturers The development of various enabling technologies has been critical in expanding the potential of biocatalytic processing, as well as in promoting its uptake across the pharmaceutical industry. 2-Chloro-3-Fluoro-4-Carboxypyridine suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. 1H-Pyrazol-1-amine,3-methyl-4-nitro-(9CI) vendor & factory Such investment is by no means prohibitive and can reap substantial rewards that include shorter development timelines, lower costs, faster time to market, and game changing technological advantage for sustainable competitive edge. ,The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria.